ARVO 2024: Functional microperimetric correlates of OCT structural features in AMD

News
Video

At the ARVO meeting in Seattle, Washington, the Eye Care Network spoke with Giulia Corradetti, MD about AMD

At this year's ARVO meeting in Seattle, Washington, Giulia Corradetti, MD, gave a research presentation titled "Functional Microperimetric Correlates of OCT Structures Features in Intermediate Age-related Macular Degeneration." In a conversation with the Eye Care Network, Dr Corradetti, who is a research scientist at Doheny Eye Institute, explained the key findings from her work.

Editor's note: The below transcript has been lightly edited for clarity.

Giulia Corradetti, MD: At ARVO, I was presenting a talk regarding the microparametric correlates of OCT features in intermediate AMD eyes. We actually found, in our study, that the changes in microperimetry are are highly localised and dependent on the OCT features. For example, we found that precursors of atrophy like, for example, aurora has [been] described by the cam group, thin double layer sign and acquired vitelliform legions are associated with a decreased pointwise sensitivity. This is particularly important because structure to function studies offer a very important opportunity to assess and study subtle changes in intermediate AMD, prior the development of atrophy, and subsequently the permanent vision loss and could be leverage to facilitate and optimise the design of early intervention clinical trials.

As we all know, there is an unmet medical need, which is the lack of treatments for early and intermediate AMD. In order to develop novel and early intervention clinical trials, we need to enhance our knowledge of the natural history of intermediate AMD. To do so, we need to study biomarkers that could be validated, have surrogate endpoints, and could [be] used in early intervention clinical trials to bring new treatments and develop new therapeutics to patients affected by early and intermediate AMD, prior that permanent loss of vision. This specific study I presented ARVO in Seattle is a pointwise sensitivity analysis, which implies the correlation of each single micro parametric stimulus to the corresponding OCT features. The next steps are to enlarge our cohort and expand this type of analysis in terms of pointwise sensitivity to a larger data, big data in order to assess and learn more about the natural history of earlier stages of the disease.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
3 experts are featured in this series.
© 2025 MJH Life Sciences

All rights reserved.